TAB3 antibody (AA 361-712)
Quick Overview for TAB3 antibody (AA 361-712) (ABIN7171966)
Target
See all TAB3 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- AA 361-712
-
Cross-Reactivity
- Human
-
Purification
- >95%, Protein G purified
-
Immunogen
- Recombinant Human TGF-beta-activated kinase 1 and MAP3K7-binding protein 3 protein (361-712AA)
-
Isotype
- IgG
-
-
-
-
Application Notes
- Recommended dilution: IHC:1:20-1:200, IF:1:50-1:200,
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
-
Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, pH 7.4 -
Preservative
- ProClin
-
Precaution of Use
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- -20 °C,-80 °C
-
Storage Comment
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
-
- TAB3 (TGF-beta Activated Kinase 1/MAP3K7 Binding Protein 3 (TAB3))
-
Alternative Name
- TAB3
-
Background
-
Background: Adapter linking MAP3K7/TAK1 and TRAF6 or TRAF2. Mediator of MAP3K7 activation, respectively in the IL1 and TNF signaling pathways. Plays a role in activation of NF-kappa-B and AP1 transcription factor. Isoform 2 may be an oncogenic factor.
Aliases: MAP3K7IP 3 antibody, Mitogen-activated protein kinase kinase kinase 7-interacting protein 3 antibody, NAP1 antibody, NF-kappa-B-activating protein 1 antibody, NFkB activating protein 1 antibody, TAB-3 antibody, Tab3 antibody, TAB3_HUMAN antibody, TAK1 binding protein 3 antibody, TAK1-binding protein 3 antibody, TGF-beta-activated kinase 1 and MAP3K7-binding protein 3 antibody, TGF-beta-activated kinase 1-binding protein 3 antibody
-
UniProt
- Q8N5C8
-
Pathways
- TLR Signaling, Fc-epsilon Receptor Signaling Pathway, Activation of Innate immune Response, Toll-Like Receptors Cascades
Target
-